Aethlon Medical: Recent News and Updates
Company Profile
Aethlon Medical Inc. (AEMD) is a medical therapeutic company focused on developing and commercializing innovative treatments for cancer and other life-threatening diseases.
Recent News
June 27, 2024: Aethlon Medical announced financial results for the fiscal first quarter ended June 30, 2024. The company reported revenue of $5.2 million and a net loss of $1.9 million.
August 14, 2023: Aethlon Medical released financial results for the first quarter ended June 30, 2023. The company had cash and cash equivalents of $4.3 million and total assets of $14.2 million.
June 20, 2024: Aethlon Medical announced that it would release fiscal first quarter financial results and host a conference call on August 14.
June 6, 2024: Aethlon Medical presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, where it shared data on its investigational cancer therapy, Hemopurifier.
Komentar